3rd Quarter - Report

VENN STRATEGIES for ELI LILLY AND COMPANY

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation and innovation policies.

LobbyistCovered position, as disclosed
SKYLAR BORCHARDT —
AUSTIN TYLER ROBERTS —
MICHAEL SPIRA —

Contacted: White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.